
Sign up to save your podcasts
Or
Emily Willingham is a journalist, scientist, and award winning skeptical blogger, with much of her work centered on autism and debunking junk science controversies. Recently the autism community has shown a surge in support for medical cannabis, as anti-vaccination activists claim that cannabis may hold the key for a cure, and many people with autism claim it to be a useful for controlling their symptoms. Willingham and host Lindsay Beyerstein delve further into the topic to sort through the misconceptions that exist on both sides of the debate.
Willingham explains that the data is limited on the relationship between cannabis and autism, in part because of the strict research restrictions that have been placed on what the government classifies as a Schedule I substance, a drug with no medical value. Despite the abundance of data showing its benefits and safety in regard to pain relief and inducing appetite, Willingham points out that the stigma against cannabis has lead to restrictions that are even more severe than those that exist on many other pain killers and opioids.
Emily Willingham will also be speaking at the upcoming Women in Secularism conference, September 23-25 in Arlington, VA. For more information go to womeninsecularism.org.
5
55 ratings
Emily Willingham is a journalist, scientist, and award winning skeptical blogger, with much of her work centered on autism and debunking junk science controversies. Recently the autism community has shown a surge in support for medical cannabis, as anti-vaccination activists claim that cannabis may hold the key for a cure, and many people with autism claim it to be a useful for controlling their symptoms. Willingham and host Lindsay Beyerstein delve further into the topic to sort through the misconceptions that exist on both sides of the debate.
Willingham explains that the data is limited on the relationship between cannabis and autism, in part because of the strict research restrictions that have been placed on what the government classifies as a Schedule I substance, a drug with no medical value. Despite the abundance of data showing its benefits and safety in regard to pain relief and inducing appetite, Willingham points out that the stigma against cannabis has lead to restrictions that are even more severe than those that exist on many other pain killers and opioids.
Emily Willingham will also be speaking at the upcoming Women in Secularism conference, September 23-25 in Arlington, VA. For more information go to womeninsecularism.org.
6,054 Listeners
38,655 Listeners
2,654 Listeners
38,203 Listeners
2,832 Listeners
4,040 Listeners
3,192 Listeners
26,359 Listeners
43,391 Listeners
918 Listeners
4,135 Listeners
8,617 Listeners
1,967 Listeners
538 Listeners
705 Listeners